The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 21, 2022

Filed:

Aug. 13, 2020
Applicant:

Janssen Vaccines & Prevention B.v., Leiden, NL;

Inventors:

Lucy Rutten, Rijnsburg, NL;

Daphné Truan, Haarlem, NL;

Nika Mindy Strokappe, Utrecht, NL;

Johannes P. M. Langedijk, Amsterdam, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/16 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); A61K 39/21 (2006.01); C12N 7/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/162 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); C07K 14/005 (2013.01); A61K 2039/53 (2013.01); C12N 7/02 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01);
Abstract

Human immunodeficiency virus (HIV) envelope proteins having mutations that stabilize the trimeric form of the envelope protein are provided. The HIV envelope proteins have certain amino acid substitutions at specified positions in the envelope protein sequence. The HIV envelope proteins described herein have an improved percentage of trimer formation and/or an improved trimer yield as compared to an HIV envelope protein that does not have one or more of the indicated amino acid substitutions. Also provided are nucleic acid molecules and vectors encoding the HIV envelope proteins, as well as compositions containing the HIV envelope proteins, nucleic acid, and vectors.


Find Patent Forward Citations

Loading…